BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37366802)

  • 1.
    Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
    J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
    Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
    Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
    Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
    BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
    Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
    BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-λ4 is associated with increased risk and earlier occurrence of several common infections in African children.
    Prokunina-Olsson L; Morrison RD; Obajemu A; Mahamar A; Kim S; Attaher O; Florez-Vargas O; Sidibe Y; Onabajo OO; Hutchinson AA; Manning M; Kwan J; Brand N; Dicko A; Fried M; Albert PS; Mbulaiteye SM; Duffy PE
    Genes Immun; 2021 May; 22(1):44-55. PubMed ID: 33850301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
    J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
    Waldenström J; Kåberg M; Alanko Blomé M; Widell A; Björkman P; Nilsson S; Hammarberg A; Weiland O; Nyström K; Lagging M
    Scand J Gastroenterol; 2021 Jul; 56(7):855-861. PubMed ID: 34034600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
    Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P
    Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
    O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
    J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.
    Bhushan A; Chinnaswamy S
    Gene; 2018 Jul; 664():168-180. PubMed ID: 29705128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Inactive Isoform with a Restored Reading Frame Is Expressed from the Human Interferon Lambda 4 TT Allele at rs368234815.
    Bharatiya S; Agarwal A; Chinnaswamy S
    J Interferon Cytokine Res; 2023 Sep; 43(9):370-378. PubMed ID: 36880961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4).
    Key FM; Peter B; Dennis MY; Huerta-Sánchez E; Tang W; Prokunina-Olsson L; Nielsen R; Andrés AM
    PLoS Genet; 2014 Oct; 10(10):e1004681. PubMed ID: 25329461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.
    Onabajo OO; Wang F; Lee MH; Florez-Vargas O; Obajemu A; Tanikawa C; Vargas JM; Liao SF; Song C; Huang YH; Shen CY; Banday AR; O'Brien TR; Hu Z; Matsuda K; Prokunina-Olsson L
    Front Immunol; 2021; 12():692263. PubMed ID: 34497603
    [No Abstract]   [Full Text] [Related]  

  • 14. IFN-λ4: the paradoxical new member of the interferon lambda family.
    O'Brien TR; Prokunina-Olsson L; Donnelly RP
    J Interferon Cytokine Res; 2014 Nov; 34(11):829-38. PubMed ID: 24786669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFNL4: Notable variants and associated phenotypes
    Fang MZ; Jackson SS; O'Brien TR
    Gene; 2020 Mar; 730():144289. PubMed ID: 31846709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.
    Eslam M; McLeod D; Kelaeng KS; Mangia A; Berg T; Thabet K; Irving WL; Dore GJ; Sheridan D; Grønbæk H; Abate ML; Hartmann R; Bugianesi E; Spengler U; Rojas A; Booth DR; Weltman M; Mollison L; Cheng W; Riordan S; Mahajan H; Fischer J; Nattermann J; Douglas MW; Liddle C; Powell E; Romero-Gomez M; George J;
    Nat Genet; 2017 May; 49(5):795-800. PubMed ID: 28394349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden.
    Lu YF; Goldstein DB; Urban TJ; Bradrick SS
    Virology; 2015 Feb; 476():334-340. PubMed ID: 25577150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
    Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y
    J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?
    O'Brien TR; Jackson SS
    J Interferon Cytokine Res; 2019 Oct; 39(10):618-626. PubMed ID: 31161939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
    Peiffer KH; Sommer L; Susser S; Vermehren J; Herrmann E; Döring M; Dietz J; Perner D; Berkowski C; Zeuzem S; Sarrazin C
    Hepatology; 2016 Jan; 63(1):63-73. PubMed ID: 26406534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.